Documente Academic
Documente Profesional
Documente Cultură
PD is a chronic, slow, progressive disorder caused by loss of dopaminergic neurons in the substantia nigra of the basal ganglia.
Risk factors of PD
Race Life experiences (trauma, emotional stress, personality traits such as shyness and depressiveness)?
studies.
PATHOGENESIS
Inherited Lewy bodies & nerve cell loss in the substantia nigra
Pathophysiology
Loss of nerve cells in the pigmented nigra pars compacta Depletion of dopaminergic neurons Reduction of dopamine Reduced thalamic excitation of the motor cortex
Tremors
Resting tremors in the limb, most commonly in one hand, which disappears with voluntary movement. Tremors occur in distal portions of extremities & especially in hands. Pill rolling motion in hands.
Rigidity of muscles
Slowness of voluntary movement Stiffness associated with vague aching & discomfort of a limb Difficulty in initiating movement
Akinesia / bradycardia
Gait is slowed with dragging of the foot & decreased arm swing on the affected side.
Postural disturbance
Stooped over posture with small, shuffling steps & often a broad base on turns. Forearms are semiflexed & fingers are flexed at metacarpophalangeal joints. Pt may fall forward (propulsion) or backward (retropulsion)
Secondary manifestations
Fine motor deficits
Handwriting becomes
small & more difficult
to read.
Clumsiness & difficulty
General weakness & muscle fatigue Muscle cramps of legs, neck & trunk Cognitive changes Dementia
Excessive perspiration
Constipation Orthostatic hypotension Urinary hesitation & frequency
Diagnosis
History Physical examination MRI SPECT
EEG
MEDICAL MANAGEMENT
Neuroprotective therapies Selegiline Symptomatic supportive approach Speech therapy Physiotherapy gait training, balance maintenance, exercise Occupational therapy
Dietary supplements
Calcium intake of 1200 mg for men & 1500mg for postmenopausal women Wearing elastic stockings will help to ovoid orthostatic hypotension
Pharmacologic treatment
Five drugs
Levadopa
Dopamine antagonists Anticholinergics Antivirals Selective monamine oxidase B inhibitors
Combination therapy
Carbidopa 10-25 mg
Levadopa 100-250 mg Stalevo combination Carbidopa Levadopa Entacapone
Anticholinergic drugs
Trihexyphenidyl hydrochloride (Artane) 2-5 mg 4 times daily. Benzotropine mesylate (cogentin) 0.5 6mg daily.
Surgical management
High frequency subthalamic stimulation using an implanted electrode & pulse generator is used to control tremors.
Nursing management
Impaired physical mobility r/t rigidity, bradykinesia & weakness. High risk injury from falls r/t rigidity, bradykinesia & weakness. Body image disturbance r/t signs & symptoms of illness. Impaired communication r/t change in voice & difficulty in writing.